fbpx Skip to main content
 

Search

Janssen Search

Search results

6 SEARCH RESULTS FOR

astrazeneca

Not finding what you're looking for? Visit Janssen in your country.
PAGE 1 OF 1

JAMES F. LIST, M.D., PH.D. GLOBAL THERAPEUTIC AREA HEAD CARDIOVASCULAR & METABOLISM James F. List, M.D., Ph.D., is the Global Therapeutic Area Head of Cardiovascular & Metabolism (CVM), leading a global team focused on creating new solutions for ...

JAMES LIST, M.D., Ph.D. GLOBAL THERAPEUTIC AREA HEAD CARDIOVASCULAR & METABOLISM James F. List, M.D., Ph.D. is the Global Therapeutic Area Head of Cardiovascular & Metabolism (CVM), leading a global team focused on creating new solutions for ...

Peter M. DiBattiste, M.D. is responsible for co-leading the Cardiovascular & Metabolism (CVM) Therapeutic Area at Janssen Research & Development, setting the strategy and leading the team in discovery and development of novel therapeutics for ...

ROBERT YANG, PH.D. GLOBAL HEAD DATA SCIENCES & PREVENTION BIOMARKERS WORLD WITHOUT DISEASE ACCELERATOR As Global Head, Data Sciences & Prevention Biomarkers, World Without Disease Accelerator (WWDA), Robert leads a team focused on developing ...

KEVIN HAMILL VICE PRESIDENT JANSSEN BUSINESS DEVELOPMENT IMMUNOLOGY Kevin Hamill is Vice President, Business Development for the Immunology Therapeutic Area (TA) at Johnson & Johnson Innovation, Janssen Business Development. In this role, he leads all ...

Sep 08, 2020 United States Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines   NEW YORK, September 8, 2020 — The CEOs of AstraZeneca (LSE ...

6 SEARCH RESULTS FOR

astrazeneca

Not finding what you're looking for? Visit Janssen in your country.
PAGE 1 OF 1